Fig. 3From: Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trialThe graph shows the mean change in creatinine (µmol/L). The bars indicate median and interquartile range of creatinine over the 24 weeks in the lithium and placebo arms respectivelyBack to article page